Intravenous lignocaine pretreatment to prevent intraocular pressure rise following suxamethonium and tracheal intubation.
AUTOR(ES)
Murphy, D F
RESUMO
Intravenous lignocaine (1.5 mg kg-1) was evaluated in patients undergoing intraocular surgery as a means of preventing the rise in intraocular pressure which accompanies tracheal intubation. In patients given either suxamethonium or pancuronium to facilitate tracheal intubation, lignocaine pretreatment conferred no benefit over placebo in preventing the intraocular hypertensive response.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1040779Documentos Relacionados
- Attenuation of ocular and systemic responses to tracheal intubation by intravenous lignocaine.
- Prevention of intraocular pressure rise following intravitreal injection.
- Adherence of Pseudomonas aeruginosa to tracheal cells injured by influenza infection or by endotracheal intubation.
- Tracheal laceration with massive subcutaneous emphysema: a rare complication of endotracheal intubation.
- Prevention of the immediate intraocular pressure rise following argon laser trabeculoplasty.
